Nocera, Inc. (NCRA) stock
NCRANasdaqAgricultural Prod-Livestock & Animal SpecialtiesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q/A on Oct 2, 2026Score 10/3065% below fair value
$1.38−0.02 (-1.43%)
Close on Nov 13, 2026Market cap $3.34MP/E –Yield –
Nocera EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Nocera's EPS for the twelve months ending Jun 30, 2026 was -$8.06. For fiscal 2025 it was -$6.15. The highest annual figure on record is $7.92 in fiscal 2018.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$6.15 | – |
| FY2024 | Dec 31, 2024 | -$9.54 | – |
| FY2023 | Dec 31, 2023 | -$12.50 | – |
| FY2022 | Dec 31, 2022 | -$18.03 | – |
| FY2021 | Dec 31, 2021 | -$46.46 | – |
| FY2020 | Dec 31, 2020 | -$2.38 | – |
| FY2019 | Dec 31, 2019 | -$4.50 | -156.8% |
| FY2018 | Dec 31, 2018 | $7.92 | – |
| FY2017 | Dec 31, 2017 | -$0.00 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$0.99 | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.63 | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.35 | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.08 | – |
| Q2 FY2025 | Jun 30, 2025 | -$0.66 | -455.5% |
| Q1 FY2025 | Mar 31, 2025 | -$0.52 | – |
| Q4 FY2024 | Dec 31, 2024 | -$7.23 | – |
| Q3 FY2024 | Sep 30, 2024 | -$0.68 | – |
| Q2 FY2024 | Jun 30, 2024 | $0.19 | – |
| Q1 FY2024 | Mar 31, 2024 | -$0.71 | – |
| Q4 FY2023 | Dec 31, 2023 | -$7.39 | – |
| Q3 FY2023 | Sep 30, 2023 | -$0.78 | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.01 | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.14 | – |
| Q4 FY2022 | Dec 31, 2022 | -$8.88 | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.15 | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.58 | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.34 | -2196.3% |
| Q4 FY2021 | Dec 31, 2021 | -$44.78 | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.32 | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.32 | -1668.4% |
| Q1 FY2021 | Mar 31, 2021 | $0.16 | -71.0% |
| Q4 FY2020 | Dec 31, 2020 | -$1.01 | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.40 | – |
| Q2 FY2020 | Jun 30, 2020 | $0.08 | – |
| Q1 FY2020 | Mar 31, 2020 | $0.55 | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.17 | -138.1% |
| Q3 FY2019 | Sep 30, 2019 | -$0.27 | – |
| Q2 FY2019 | Jun 30, 2019 | -$0.49 | – |
| Q1 FY2019 | Mar 31, 2019 | -$0.57 | – |
| Q4 FY2018 | Dec 31, 2018 | $8.31 | – |
| Q3 FY2018 | Sep 30, 2018 | -$0.23 | – |
| Q2 FY2018 | Jun 30, 2018 | -$0.13 | – |
| Q1 FY2018 | Mar 31, 2018 | -$0.04 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?